Literature DB >> 8955645

A broad-host-range in vivo pop-out and amplification system for generating large quantities of 50- to 100-kb genomic fragments for direct DNA sequencing.

J Wild1, Z Hradecná, G Pósfai, W Szybalski.   

Abstract

A prerequisite for sequencing large genomes is to obtain 30- to 150-kb genomic DNA fragments in adequate quantity. Previously, we developed a system which enables one to excise and amplify in vivo such segments directly from the Escherichia coli genome. This system, which employed the yeast Flp/FRT elements for excision and the plasmid R6K-based replication machinery for DNA amplification, permits one to bypass conventional cloning [Pósfai et al. (1994) Nucleic Acids Res. 22, 2392-2398]. To extend the applicability of such a system to many species, we describe here a broad-host-range (bhr) system in which the amplification of the excised DNA fragment depends on the oriV element and the Rep (TrfA) protein from the promiscuous RK2/RP4 plasmid. We have constructed insertion plasmids which carry the FRT and oriV sites. To introduce such plasmids into the appropriate position in the host genome, a short genomic sequence homologous to this position was cloned into the multiple cloning site (MCS) of the FRT/oriV insertion plasmid and then recombined into this position in the genome by RecA-mediated recombination. In such a manner, many strains with single FRT/oriV insertions at various positions could be generated. Subsequent genetic crosses or phage transduction allow two neighboring FRT/oriV sites (less than 150 kb apart) to be brought into a single genome. In the present report, the lacZ and phoB sites, which are 51 kb apart in the E. coli genome, were used for the introduction of the FRT/oriV sites. To deliver the Flp (excision) and Rep (amplification) functions in trans, the yeast FLP and RK2 plasmid trfA genes were placed under the control of the Ptet promoter/operator which is tightly regulated by the TetR repressor. The addition of heated chlortetracycline (cTc) inactivates TetR, turning on the synthesis of Flp and TrfA, which respectively, execute (i) excision of the 51-kb genomic segment between the two FRT sites (in lacZ and in phoB), and (ii) its amplification.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955645     DOI: 10.1016/s0378-1119(96)00487-8

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  High-frequency flp recombinase-mediated inversions of the oriC-containing region of the Pseudomonas aeruginosa genome.

Authors:  N Barekzi; K Beinlich; T T Hoang; X Q Pham; R Karkhoff-Schweizer; H P Schweizer
Journal:  J Bacteriol       Date:  2000-12       Impact factor: 3.490

2.  An improved method for oriT-directed cloning and functionalization of large bacterial genomic regions.

Authors:  Brian H Kvitko; Ian A McMillan; Herbert P Schweizer
Journal:  Appl Environ Microbiol       Date:  2013-06-07       Impact factor: 4.792

3.  Tightly controlled two-stage expression vectors employing the Flp/FRT-mediated inversion of cloned genes.

Authors:  M Sektas; W Szybalski
Journal:  Mol Biotechnol       Date:  1998-02       Impact factor: 2.695

Review 4.  Chromosomal editing in Escherichia coli. Vectors for DNA integration and excision.

Authors:  P Balbás; G Gosset
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

5.  Chromosomal integration of heterologous DNA in Escherichia coli with precise removal of markers and replicons used during construction.

Authors:  F Martinez-Morales; A C Borges; A Martinez; K T Shanmugam; L O Ingram
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

6.  oriT-directed cloning of defined large regions from bacterial genomes: identification of the Sinorhizobium meliloti pExo megaplasmid replicator region.

Authors:  P S Chain; I Hernandez-Lucas; B Golding; T M Finan
Journal:  J Bacteriol       Date:  2000-10       Impact factor: 3.490

7.  Reduced evolvability of Escherichia coli MDS42, an IS-less cellular chassis for molecular and synthetic biology applications.

Authors:  Kinga Umenhoffer; Tamás Fehér; Gabriella Balikó; Ferhan Ayaydin; János Pósfai; Frederick R Blattner; György Pósfai
Journal:  Microb Cell Fact       Date:  2010-05-21       Impact factor: 5.328

8.  Engineering Heterologous Production of Salicylate Glucoside and Glycosylated Variants.

Authors:  Ruiquan Qi; Blaine A Pfeifer; Guojian Zhang
Journal:  Front Microbiol       Date:  2018-09-20       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.